Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Acrivon, Adaptive, Alphamab, Astrazeneca, Catalyst, Freya, Genentech, Radiopharm, Rocket, Salarius.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Carsgen, Valeo.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Boan, D&D, Eirgenix, Golden, Hyundai, Revive, Transcenta.